Tue, 22 December 2020
In this episode of Practice Pearls: Overcoming Therapeutic Inertia Drs. Robert Gabbay and Dr. Kamlesh Khunti discuss an overview of Therapeutic Inertia and the American Diabetes Associations initiative on overcoming therapeutic inertia. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.
This episode is sponsored by the Overcoming Therapeutic Inertia Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org .
Robert Gabbay, MD, PhD, FACP, Chief Scientific and Medical Officer, American Diabetes Association
Kamlesh Khunti, MD, PhD, Professor of Primary Care Diabetes & Vascular Medicine, University of Leicester, Leicester General Hospital, Leicester, UK
Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health